Evidence map›Paper›PMID 42238104›Full record

ArticleJournal of causal inference2024

An approach to nonparametric inference on the causal dose-response function.

Aaron Hudson, Elvin H Geng, Thomas A Odeny, Elizabeth A Bukusi, Maya L Petersen, Mark J van der Laan

Abstract read
In one paragraph

Article in Journal of causal inference, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aaron HudsonVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Elvin H GengDivision of Infectious Diseases, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
Thomas A OdenyResearch Care Training Program, Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Elizabeth A BukusiResearch Care Training Program, Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Maya L PetersenDivision of Biostatistics, School of Public Health, University of California, Berkeley, California, United States.
Mark J van der LaanDivision of Biostatistics, School of Public Health, University of California, Berkeley, California, United States.

Funding

Targeted Learning using adaptive designs for HIV Epidemic control in East AfricaR01AI074345 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PETERSEN, MAYA LIV, VANDERLAAN, MARK J · 2007 to 2023
$6.6M
Adaptive Strategies for Preventing & Treating Lapses of Retention in Care (AdaPT)R01MH104123 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, CRAIG R, PETERSEN, MAYA LIV · 2014 to 2018
$3.4M
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CAREK24AI134413 · NIAID · WASHINGTON UNIVERSITY · PI Elvin H. Geng · 2017 to 2026
$1.4M
NIAID NIH HHS K24 AI134413NIAID NIH HHS R01 AI074345NIMH NIH HHS R01 MH104123
6 · The paper itself

Abstract

The causal dose-response curve is commonly selected as the statistical parameter of interest in studies where the goal is to understand the effect of a continuous exposure on an outcome. Most of the available methodology for statistical inference on the dose-response function in the continuous exposure setting requires strong parametric assumptions on the probability distribution. Such parametric assumptions are typically untenable in practice and lead to invalid inference. It is often preferable to instead use nonparametric methods for inference, which only make mild assumptions about the data-generating mechanism. We propose a nonparametric test of the null hypothesis that the dose-response function is equal to a constant function. We argue that when the null hypothesis holds, the dose-response function has zero variance. Thus, one can test the null hypothesis by assessing whether there is sufficient evidence to claim that the variance is positive. We construct a novel estimator for the variance of the dose-response function, for which we can fully characterize the null limiting distribution and thus perform well-calibrated tests of the null hypothesis. We also present an approach for constructing simultaneous confidence bands for the dose-response function by inverting our proposed hypothesis test. We assess the validity of our proposal in a simulation study. In a data example, we study, in a population of patients who have initiated treatment for HIV, how the distance required to travel to an HIV clinic affects retention in care.

Indexed as

62G0562G10continuous exposuredose–response functionnonparametric testingtargeted minimum loss-based estimation

Identifiers

PMID42238104
PMCPMC13229544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.